Sonoma Pharmaceuticals announced that Microcyn Rx products have received a Distribution and Pricing Agreement for distribution by the Defense Logistics Agency. The DAPA enables our partner, EMC Pharma, to enter into distribution agreements for Microcyn Rx products with federal customers. The U.S. government is the world’s largest purchaser of good and services. Approximately half of EMC Pharma’s customers are U.S. government entities, including VA hospitals, the Department of Defense, the Federal Bureau of Prisons, as well as state and local prison systems. EMC Pharma is a 100% minority-owned and a certified Minority Business Enterprise. The DAPA approval process was a coordinated effort by Sonoma and EMC Pharma and resulted in obtaining DAPA # SP0200-22-H-0034 for Sonoma’s Microcyn Rx products including wound care, prescription dermatology products, Celacyn and Levicyn, and prescription eye care Acuicyn.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SNOA:
